Article Sidebar
Published:
Jul 9, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Effect of <i>Nuangong zhitong</i> decoction on primary dysmenorrhea in mice
Abstract
Purpose: To investigate the therapeutic effect of Nuangong Zhitong decoction (NZD) on primary dysmenorrhea (PD) in mice, and its mechanism of action.
Methods: Dysmenorrhea was established in female PD mice by intraperitoneal injection of oxytocin following estradiol benzoate pretreatment. The effects of NZD and its active principles (cinnamic aldehyde and cinnamic acid) on PD were determined using body twist method. Serum levels of prostaglandin E2 (PGE2) and prostaglandin F2 alpha (PGF2α) in mice were measured using ELISA.
Results: The results showed that NZD dose-dependently reduced oxytocin-induced writhing responses (p < 0.05). Moreover, cinnamic aldehyde and cinnamic acid reduced oxytocin-induced writhing responses in a concentration-dependent manner, with maximal inhibitions of 65.01 and 70.67 %, respectively, and also decreased serum levels of PGE2 and PGF2α in PD mice (p < 0.05).
Conclusion: These results indicate that NZD mitigates oxytocin-induced uterine tetanic contraction in mice. Thus, NZD has a potential for development into an anti-dysmenorrheal drug for use in humans.
